Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 383

1.

Age-dependent morbidity and mortality outcomes after surgical aortic valve replacement.

Hussain AI, Auensen A, Brunborg C, Beitnes JO, Gullestad L, Pettersen KI.

Interact Cardiovasc Thorac Surg. 2018 May 9. doi: 10.1093/icvts/ivy154. [Epub ahead of print]

PMID:
29746650
2.

The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event.

Munkhaugen J, Otterstad JE, Dammen T, Gjertsen E, Moum T, Husebye E, Gullestad L.

Eur J Prev Cardiol. 2018 Jan 1:2047487318768940. doi: 10.1177/2047487318768940. [Epub ahead of print]

PMID:
29635941
3.

The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions.

Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE.

Heart Fail Rev. 2018 May;23(3):303-323. doi: 10.1007/s10741-018-9685-0. Review.

4.

The follow-up after myocardial infarction - is it good enough?

Munkhaugen J, Peersen K, Sverre E, Gjertsen E, Gullestad L, Dammen T, Husebye E, Otterstad JE.

Tidsskr Nor Laegeforen. 2018 Mar 5;138(5). doi: 10.4045/tidsskr.17.1050. Print 2018 Mar 6. English, Norwegian. No abstract available.

5.

Importance of physical capacity and the effects of exercise in heart transplant recipients.

Yardley M, Gullestad L, Nytrøen K.

World J Transplant. 2018 Feb 24;8(1):1-12. doi: 10.5500/wjt.v8.i1.1. Review.

6.

Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.

Cosmi F, Shen L, Magnoli M, Abraham WT, Anand IS, Cleland JG, Cohn JN, Cosmi D, De Berardis G, Dickstein K, Franzosi MG, Gullestad L, Jhund PS, Kjekshus J, Køber L, Lepore V, Lucisano G, Maggioni AP, Masson S, McMurray JJV, Nicolucci A, Petrarolo V, Robusto F, Staszewsky L, Tavazzi L, Teli R, Tognoni G, Wikstrand J, Latini R.

Eur J Heart Fail. 2018 May;20(5):888-895. doi: 10.1002/ejhf.1146. Epub 2018 Feb 28.

PMID:
29488676
7.

Determinants and Outcome of Decision Making Among Patients with Severe Aortic Stenosis.

Hussain AI, Auensen A, Brunborg C, Aakhus S, Fiane A, Pettersen KI, Gullestad L.

J Heart Valve Dis. 2017 Jul;26(4):413-422.

PMID:
29302940
8.

Immediate response in markers of inflammation and angiogenesis during exercise: a randomised cross-over study in heart transplant recipients.

Yardley M, Ueland T, Aukrust P, Michelsen A, Bjørkelund E, Gullestad L, Nytrøen K.

Open Heart. 2017 Nov 28;4(2):e000635. doi: 10.1136/openhrt-2017-000635. eCollection 2017.

9.

Optimal blood pressure control after coronary events: the challenge remains.

Sverre E, Peersen K, Otterstad JE, Gullestad L, Perk J, Gjertsen E, Moum T, Husebye E, Dammen T, Munkhaugen J.

J Am Soc Hypertens. 2017 Dec;11(12):823-830. doi: 10.1016/j.jash.2017.10.007. Epub 2017 Oct 28.

PMID:
29128603
10.

Cognitive function among long-term survivors of heart transplantation.

Bürker BS, Gude E, Gullestad L, Grov I, Relbo Authen A, Andreassen AK, Havik OE, Dew MA, Fiane AE, Haraldsen IR, Malt UF, Andersson S.

Clin Transplant. 2017 Dec;31(12). doi: 10.1111/ctr.13143. Epub 2017 Nov 15.

PMID:
29055147
11.

Health-related quality of life in older patients with acute coronary syndrome randomised to an invasive or conservative strategy. The After Eighty randomised controlled trial.

Tegn N, Abdelnoor M, Aaberge L, Hylen Ranhoff A, Endresen K, Gjertsen E, Skårdal R, Gullestad L, Bendz B; After Eighty study investigators.

Age Ageing. 2018 Jan 1;47(1):42-47. doi: 10.1093/ageing/afx121.

PMID:
28985265
12.

Patient-reported outcomes after referral for possible valve replacement in patients with severe aortic stenosis.

Auensen A, Hussain AI, Garratt AM, Gullestad LL, Pettersen KI.

Eur J Cardiothorac Surg. 2018 Jan 1;53(1):129-135. doi: 10.1093/ejcts/ezx228.

PMID:
28977361
13.

Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study.

Welsh P, Kou L, Yu C, Anand I, van Veldhuisen DJ, Maggioni AP, Desai AS, Solomon SD, Pfeffer MA, Cheng S, Gullestad L, Aukrust P, Ueland T, Swedberg K, Young JB, Kattan MW, Sattar N, McMurray JJV.

Eur J Heart Fail. 2018 Feb;20(2):268-277. doi: 10.1002/ejhf.988. Epub 2017 Sep 27.

PMID:
28960777
14.

Medical and sociodemographic factors predict persistent smoking after coronary events.

Sverre E, Otterstad JE, Gjertsen E, Gullestad L, Husebye E, Dammen T, Moum T, Munkhaugen J.

BMC Cardiovasc Disord. 2017 Sep 6;17(1):241. doi: 10.1186/s12872-017-0676-1.

15.

The predictive value of coronary artery calcium detected by computed tomography in a prospective study on cardiac allograft vasculopathy in heart transplant patients.

Günther A, Andersen R, Gude E, Jakobsen J, Edvardsen T, Sandvik L, Abildgaard A, Aaberge L, Gullestad L.

Transpl Int. 2018 Jan;31(1):82-91. doi: 10.1111/tri.13057. Epub 2017 Sep 21.

PMID:
28865096
16.

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators.

N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.

17.

Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure.

Mayerhofer CCK, Ueland T, Broch K, Vincent RP, Cross GF, Dahl CP, Aukrust P, Gullestad L, Hov JR, Trøseid M.

J Card Fail. 2017 Sep;23(9):666-671. doi: 10.1016/j.cardfail.2017.06.007. Epub 2017 Jul 5.

PMID:
28688889
18.

Morbidity outcomes after surgical aortic valve replacement.

Auensen A, Hussain AI, Bendz B, Aaberge L, Falk RS, Walle-Hansen MM, Bye J, Andreassen J, Beitnes JO, Rein KA, Pettersen KI, Gullestad L.

Open Heart. 2017 Apr 13;4(1):e000588. doi: 10.1136/openhrt-2017-000588. eCollection 2017.

19.

The role of cardiac rehabilitation in secondary prevention after coronary events.

Peersen K, Munkhaugen J, Gullestad L, Liodden T, Moum T, Dammen T, Perk J, Otterstad JE.

Eur J Prev Cardiol. 2017 Sep;24(13):1360-1368. doi: 10.1177/2047487317719355. Epub 2017 Jun 30.

PMID:
28664773
20.

Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE).

Relbo Authen A, Grov I, Karason K, Gustafsson F, Eiskjaer H, Rådegran G, Gude E, Jansson K, Dellgren G, Solbu D, Arora S, Andreassen AK, Gullestad L.

Clin Transplant. 2017 Sep;31(9). doi: 10.1111/ctr.13038. Epub 2017 Jul 19.

PMID:
28640529

Supplemental Content

Loading ...
Support Center